针对抗FcRn片段抗体efgartigimod的转化群体目标结合模型
Sven Hoefman1, Tamara van Steeg2, Ingrid Ottevaere3
1LAP&P Consultants BV, Archimedesweg 31, Leiden, CM 2333, The Netherlands. S.Hoefman@lapp.nl.
Journal of pharmacokinetics and pharmacodynamics
|December 5, 2024
概括
作为新生儿Fc受体 (FcRn) 阻断剂的efgartigimod有效降低了自身免疫性疾病中的IgG水平. 它的药理动力学-药理动力学模型通过考虑FcRn结合亲缘关系,准确地预测了物种间的IgG减少.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 药物开发 药物开发
背景情况:
- Efgartigimod是一种IgG1抗体片段,旨在通过阻断新生儿Fc受体 (FcRn) 来治疗IgG介导的自身免疫性疾病.
- 它被设计为与FcRn结合的高亲和力,促进IgG降解而不是回收.
研究的目的:
- 为efgartigimod.de开发和验证一个人群药理动力学-药理动力学 (PKPD) 模型.
- 描述和预测efgartigimod在不同物种的PKPD,包括人类,Cynomolgus子,子,老鼠和小鼠.
主要方法:
- 使用从健康志愿者研究的数据开发了一个人群PKPD模型.
- 该模型结合了FcRn结合和药物诱导的FcRn受体占用,以解释总的IgG抑制.
- 该模型被推断为临床前物种,考虑到特定物种的FcRn结合亲缘关系和全米缩放.
主要成果:
- 该PKPD模型成功地描述了人类的efgartigimod血清水平和总IgG概况.
- 在efgartigimod的PKPD中,物种之间的差异是由FcRn结合亲和力和生理参数的变化解释的.
- 在体外-体内缩放对于准确预测跨物种药物效应至关重要.
结论:
- Efgartigimod的PKPD的有效特征是与FcRn.的标结合.
- 结合FcRn的高亲和力保护efgartigimod免受排泄,导致持续的IgG减少.
- 开发的模型证明了PKPD从临床前物种成功转化到人类,支持efgartigimod的治疗潜力.
相关概念视频
Improving Translational Accuracy
Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
Leaky Scanning
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...


